Nutrition labeling hearings
FDA will convene hearings Jan. 30-31 to obtain public comment on its recently proposed regulations to revamp nutrition labeling ("The Pink Sheet" Dec. 9, p. 11; Dec. 2, p. 20). The hearings will begin at 8:00 a.m. both days in the Masur Auditorium at NIH's Bethesda, Md. campus.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth